Frontiers in Oncology (Sep 2020)

Commentary: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer

  • Rafael Rosell,
  • Martyna Filipska,
  • Imane Chaib,
  • David Lligé,
  • Fernando Laguia

DOI
https://doi.org/10.3389/fonc.2020.01726
Journal volume & issue
Vol. 10

Abstract

Read online

No abstracts available.

Keywords